MCL1 and lymphoma: Because these genes are thought to drive tumorigenesis, the genetic status and expression level of MYC and MCL1 for each line is indicated (25); however, the correlations between these aberrations and enitociclib sensitivity and resistance were not possible as most lymphoma cell lines are sensitive to enitociclib treatment (Supplementary Table S1).